Lisinopril and Hydrochlorothiazide
- Product NDC
- 55700-799
- 11-digit product format
- 557000799
- Labeler code
- 55700
- Product ID
- 55700-799_68de9422-ee46-4b0e-a80d-81df6a2a4314
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Quality Care Products, LLC
- Application
- ANDA076194
- Marketing category
- ANDA
- Marketing start
- 2019-10-11
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL; HYDROCHLOROTHIAZIDE
- Active strength
- 20 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55700-799-30 | 55700079930 | 30 TABLET in 1 BOTTLE, PLASTIC (55700-799-30) | 30 tablet | 2019-10-11 | 0000-00-00 | No | No | Current |
| 55700-799-90 | 55700079990 | 90 TABLET in 1 BOTTLE, PLASTIC (55700-799-90) | 90 tablet | 2020-08-14 | 0000-00-00 | No | No | Current |